We are excited to announce that Cellular and Molecular Life Sciences has now become a fully open access (OA) journal as of May 3rd 2024. This means that we will only be publishing articles as Open Access meaning content will be and freely available to readers worldwide, enabling the widest possible dissemination and reuse.
Defence is the Best Attack, 13-15 May 2025, is an opportunity to learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies, including the identification of novel targets. Register here.
The 2025 Annual Congress of the European Association for Cancer Research (EACR 2025) is a four-day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.
© Springer Nature Switzerland AG
